PRATESI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 16.576
AS - Asia 4.215
EU - Europa 3.123
SA - Sud America 753
AF - Africa 266
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 24.942
Nazione #
US - Stati Uniti d'America 13.993
CA - Canada 2.502
CN - Cina 1.264
SG - Singapore 1.238
IT - Italia 941
HK - Hong Kong 792
BR - Brasile 613
SE - Svezia 526
DE - Germania 340
BG - Bulgaria 308
GB - Regno Unito 270
VN - Vietnam 264
RU - Federazione Russa 149
TR - Turchia 145
FI - Finlandia 133
UA - Ucraina 128
CI - Costa d'Avorio 108
IN - India 104
KR - Corea 89
AT - Austria 68
BD - Bangladesh 60
AR - Argentina 56
BE - Belgio 49
CH - Svizzera 46
FR - Francia 45
JP - Giappone 45
NG - Nigeria 37
IQ - Iraq 35
MX - Messico 33
SN - Senegal 31
ZA - Sudafrica 27
PL - Polonia 25
PK - Pakistan 23
ID - Indonesia 22
SA - Arabia Saudita 21
UZ - Uzbekistan 21
NL - Olanda 20
ES - Italia 19
EC - Ecuador 17
VE - Venezuela 17
CO - Colombia 12
GR - Grecia 11
IL - Israele 11
PY - Paraguay 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
EG - Egitto 10
KE - Kenya 10
NP - Nepal 10
IR - Iran 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
MA - Marocco 8
JM - Giamaica 7
CL - Cile 6
HN - Honduras 6
LB - Libano 6
LT - Lituania 6
PE - Perù 6
BB - Barbados 5
BJ - Benin 5
DZ - Algeria 5
EU - Europa 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AU - Australia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
IE - Irlanda 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
AO - Angola 3
BH - Bahrain 3
GT - Guatemala 3
KG - Kirghizistan 3
PH - Filippine 3
PS - Palestinian Territory 3
TH - Thailandia 3
AZ - Azerbaigian 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SR - Suriname 2
TG - Togo 2
Totale 24.917
Città #
Dallas 6.148
Montreal 2.328
Woodbridge 982
Ashburn 796
Hong Kong 783
Ann Arbor 729
Singapore 620
Fairfield 615
Houston 587
Santa Clara 572
Chandler 539
Sofia 306
Shanghai 300
Beijing 293
Milan 262
Seattle 249
New York 232
Wilmington 231
Cambridge 175
Boardman 158
Jacksonville 148
Princeton 147
Pisa 144
Ottawa 139
Los Angeles 128
Lawrence 120
Hefei 117
Medford 109
Abidjan 108
Nanjing 108
Serra 91
Lancaster 84
Des Moines 83
Seoul 83
Izmir 78
Dong Ket 64
Vienna 63
London 60
Munich 58
Buffalo 55
Ho Chi Minh City 55
Livorno 47
Brussels 42
Istanbul 42
San Diego 41
São Paulo 41
Tokyo 41
Bern 40
Nanchang 38
Lagos 37
Redondo Beach 36
Rome 36
Bremen 31
Dakar 31
Florence 30
Frankfurt am Main 29
Rio de Janeiro 29
Dearborn 28
Council Bluffs 27
Hanoi 27
Chicago 26
Jüchen 26
Ogden 25
Redwood City 25
Turku 24
North Bergen 21
San Jose 21
Dhaka 20
Nuremberg 20
Tashkent 19
Tianjin 19
Warsaw 19
Hebei 18
Kunming 18
Auburn Hills 17
Helsinki 16
Jiaxing 16
Fuzhou 15
Changsha 14
Pune 14
Shenyang 14
Baghdad 13
Chennai 13
Belo Horizonte 12
Brasília 12
Columbus 12
Mexico City 12
Nürnberg 12
Quanzhou 12
Phoenix 11
The Dalles 11
Toronto 11
Düsseldorf 10
Lahore 10
Montevideo 10
Norwalk 10
San Francisco 10
Washington 10
Curitiba 9
Falls Church 9
Totale 20.236
Nome #
08.20 Acpa fingerprinting in established rheumatoid arthritis 8.476
Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis 199
Anti-endothelial cells antibodies and anti-DNA antibodies in systemic lupus erythematosus sera. 181
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 176
A Straightforward Method to Produce Multi-Nanodrug Delivery Systems for Transdermal/Tympanic Patches Using Electrospinning and Electrospray 172
IL-18 activity in systemic lupus erythematosus 171
A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera 168
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 166
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. 165
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population 163
Alpha-Enolase is an autoantigen in systemic autoimmune disorders. 163
Autoantibodies in Systemic Lupus: Quite a Lot or Just a Few? 163
A family-based study shows no association between rheumatoid arthritis and the PADI4 gene in a French caucasian population 162
The targets of nephritogenic antibodies in systemic autoimmune disorders 162
ANTI-CITRULLINATED ALPHA ENOLASE ANTIBODIES, INTERSTITIAL LUNG DISEASE AND BONE EROSION IN RHEUMATOID ARTHRITIS 162
The immune response to citrullinated antigens in autoimmune diseases 161
NETosis as Source of Autoantigens in Rheumatoid Arthritis 161
Potential biomarkers in patients with systemic sclerosis 159
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria. 159
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience 156
Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity 154
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria. 153
Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis 153
Prevalenza degli anticorpi anti-Saccharomices Cerevisiae nei pazienti affetti da spondilite anchilosante ed artrite psoriasica 152
Alpha-enolase and anti-alpha-enolase antibodies in systemic lupus. 151
IL-18 in autoimmunity. Studies in autoimmune murine lupus and in human SLE 150
Peptidylarginine deiminase 4 and citrullination in health and disease 150
Detection of anti-ribosomal P protein antibodies by means of synthetic peptides 149
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. 149
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. 148
ACPA and shared epitope: The behaviour of anti-viral citrullinated peptide antibodies 147
Deiminated Epstein Barr virus nuclear antigen I is a target of anti-citrullinated protein antibodies in rheumatoid arthritis 145
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 144
Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders 144
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight 144
IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders 143
Mediators of angiogenesis and fibrosis in IgG4-related disease. 143
IL-1 family cytokines and receptors in IgG4-related disease 141
Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference 140
Surface plasmon resonance method to evaluate anti-citrullinated protein/peptide antibody affinity to citrullinated peptides 140
Fingerprinting of anti-citrullinated protein antibodies (ACPA): Specificity, isotypes and subclasses 140
Anti-ribosomal antibodies from lupus patients bind DNA 139
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X(4) 138
Autoantibodies and nephritis: different roads may lead to Rome 138
The peptidylarginine deiminase V gene: a candidate gene in rheumatoid arthritis 137
Modified peptides as diagnostic tools for autoimmune diseases: A chemical reverse approach 137
Mechanism of renal damage in systemic autoimmune disorders 137
Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease? 136
Anti-ribosomal P protein antibodies bind cardiolipin 135
Antibodies to viral citrullinated Peptide in rheumatoid arthritis 135
Antibodies to tissue transglutaminase and Saccharomyces cerevisiase in ankylosing spondylitis and psoriatic arthritis 135
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies 134
Anti-citrullinated protein antibodies (ACPA) and antibodies to exogenous antigens in follow-up study of rheumatoid arthritis patients 134
Anti-Alpha-Enolase antibodies in mixed cryoglobulinemia. 134
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 134
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 134
Evaluation of the pathogenic role of anti-alpha enolase antibodies in autoimmune disorders. 132
Method for the diagnosis of rheumatoid arthritis 131
IgA antibodies to tissue transglutaminase in patients affected by ankilosing spondylitis and psoriatic arthritis 129
Analysis of the peptidylarginine deiminase V gene in rheumatoid arthritis 129
Heart- and skeletal muscle-specific antigens recognized by trichinellosis patient sera 128
Something old, something new: biomarkers in rheumatoid arthritis 128
Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms 128
Alpha-enolase is a renal specific antigen associated with kidney involvement in mixed cryoglobulinemia 127
Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized αenolase (methionine sulfoxide 93). 127
The 'Chemical Reverse Approach to identify autoantibodies in Systemic Lupus Erithematosus patients. 126
A new autoantigen, alpha-enolase. 126
Anti-enolase antibodies and renal damage. 126
Endogenous anti-C1q antibodies do not interfere with the C1qScreen™ assay. 125
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders 124
Anti Citrullinated Peptide Antibodies profiling in established rheumatoid arthritis 124
Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis. 124
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies 123
Flow cytometric single-cell analysis of cytokine production by CD3+ T-cells in synovial fluid from patients with psoriatic arthritis. 123
The interleukin-1 family cytokines and receptors in autoimmune and autoinflammatory diseases 122
Multiple Autoantibody Cross-reactivity in Connective Tissue Diseases 121
Mechanisms of renal damage in mixed cryoglobulinaemia nephritis 121
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis. 121
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 120
Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. 120
Surface expression of an autoantigen, alpha-enolase. 120
HLA Shared Epitope and ACPA: just a marker or an active player? 120
Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis. 120
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 119
HISTONE CITRULLINATED PEPTIDES AND USES THEREOF 118
IgG subclass profile of anti citrullinated peptide antibodies specific for EBV- and histone-derived citrullinated peptides 117
Alpha-enolase as plasminogen receptor: the activity of the autoantibodies in the receptor function. 117
Structure and function of an autoantigen, alpha-enolase. 116
Viral citrullinated peptides and uses thereof 115
Shotgun proteomics, in-silico evaluation and immunoblotting assays for allergenicity assessment of lesser mealworm, black soldier fly and their protein hydrolysates. 115
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria 114
Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome 114
IL-1 FAMILY CYTOKINES AND RECEPTORS IN IgG4-RELATED DISEASE 113
Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH). 113
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 113
Anti-Alpha-Enolase antibodies and renal damage in systemic autoimmune disorders. 112
CXCL12/SDF-1 in IgG4-Related Disease 111
Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination 110
Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans 110
Analysis of the peptidyl arginine deiminase V gene in rheumatoid arthritis 110
Totale 22.064
Categoria #
all - tutte 57.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 90 69 77 86 67 69 169
2021/20221.312 34 72 28 73 226 181 31 61 62 54 90 400
2022/20231.667 202 227 102 164 184 273 36 83 300 6 76 14
2023/20243.735 160 144 165 175 194 214 75 43 31 2.337 36 161
2024/20254.373 56 150 56 204 399 390 364 216 412 503 425 1.198
2025/20268.280 259 2.009 4.725 534 388 365 0 0 0 0 0 0
Totale 25.306